scieee Science in your language
[en] (orig)

Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children

Abstract

Most vaccines used for humans work through humoral immunity, yet many appear to be protective even after specific circulating antibody levels have waned to undetectable levels. Furthermore, it has been difficult to define a serologic correlate of protection against a number of infectious diseases, including those caused by Bordetella pertussis. B. pertussis clearance in immunized mice has been shown to correlate with pertussis vaccine efficacy in children. This murine respiratory challenge model was used to demonstrate persistent vaccine-induced protection against B. pertussis in the absence of circulating antibody at the time of challenge. Whole-cell and acellular pertussis vaccines induced persistent memory T and B cells and anamnestic antibody responses after challenge. The findings suggest that immunologic memory is more significant in protection than is the induction of immediate antibody responses and imply that vaccinated children still may be protected against disease following the disappearance of specific serum IgG.

Read accessible full text

Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children

Author: Mahon, Bernard P.,Brady, Miriam T.,Mills, Kingston H.G.
Publisher: Infectious Diseases Society of America
Year: 2000
Source: https://mural.maynoothuniversity.ie/id/eprint/168/1/JID_2000.pdf
2087
CONCISE COMMUNICATION
P o ec ion agains Bo de ella pe ussis in Mice in he Absence o De ec able
Ci cula ing An ibody: Implica ions o Long-Te m Immuni y in Child en
Be na d P. Mahon, Mi iam T. B ady,
and Kings on H. G. Mills
In ec ion and Immuni y G oup, Depa men o Biology,
Na ional Uni e si y o I eland, Maynoo h, Co. Kilda e
Mos accines used o humans wo k h ough humo al immuni y, ye many appea o be
p o ec i e e en a e speci ic ci cula ing an ibody le els ha e waned o unde ec able le els.
Fu he mo e, i has been di icul o de ine a se ologic co ela e o p o ec ion agains a numbe
o in ec ious diseases, including hose caused by Bo de ella pe ussis. B. pe ussis clea ance in
immunized mice has been shown o co ela e wi h pe ussis accine e icacy in child en. This
mu ine espi a o y challenge model was used o demons a e pe sis en accine-induced p o-
ec ion agains B. pe ussis in he absence o ci cula ing an ibody a he ime o challenge.
Whole-cell and acellula pe ussis accines induced pe sis en memo y T and B cells and
anamnes ic an ibody esponses a e challenge. The indings sugges ha immunologic mem-
o y is mo e signi ican in p o ec ion han is he induc ion o immedia e an ibody esponses
and imply ha accina ed child en s ill may be p o ec ed agains disease ollowing he dis-
appea ance o speci ic se um IgG.
Whole-cell pe ussis accines appea o induce long-las ing
immuni y agains se e e whooping cough in child en and young
adul s. Howe e , conce n abou he sa e y o whole-cell ac-
cines has esul ed in he de elopmen o acellula pe ussis ac-
cines p epa ed om pu i ied componen s o Bo de ella pe ussis.
The new accines, which ha e a highe sa e y p o ile, ha e
eplaced whole-cell accines in many de eloped coun ies. Re-
sul s om clinical ials ha e indica ed ha acellula pe ussis
accines con e ela i ely high le els o p o ec ion agains se e e
disease [1–4], bu hese s udies ha e no p o ided de ini i e
in o ma ion abou a ela ionship be ween an ibody le els
agains p o ec i e an igens and immune p o ec ion. Follow-up
s udies ha e indica ed ha an ibody esponses in immunized
child en decline o low o unde ec able le els 2 yea s a e a
comple e cou se o accina ion [5, 6]. These child en do no
appea o be de eloping o e disease [7], bu , wi hou a his o y
o exposu e and he applica ion o sensi i e indica o s o in-
ec ion in la ge pos immuniza ion su eillance p og ams, i is
impossible o de e mine whe he hey a e immune o in ec ion
and o es ablish he mechanisms ha media e p o ec ion. Al-
Recei ed 17 Decembe 1999; e ised 15 Feb ua y 2000; elec onically
published 5 June 2000.
P esen ed in pa : B i ish Socie y o Immunology Annual Cong ess, Ha -
oga e, Uni ed Kingdom, Decembe 1999 (abs ac W2.2).
Financial suppo : Wellcome T us (“New Blood” ellow o B.P.M. and
p ojec g an 052317 o K.H.G.M.); Heal h Resea ch Boa d o I eland ( o
M.T.B.).
Rep in s o co espondence: D . Kings on Mills, In ec ion and Immuni y
G oup, Dep . o Biology, Na ional Uni e si y o I eland, Maynoo h, Co.
Kilda e, I eland (kings [email protected]).
The Jou nal o In ec ious Diseases 2000;181:2087–91
q2000 by he In ec ious Diseases Socie y o Ame ica. All igh s ese ed.
0022-1899/2000/18106-0036$02.00
hough hese undamen al ques ions a e di icul o answe in
a clinical se ing, we ha e been able o add ess hem by use o
a well-es ablished animal model.
By use o a mu ine espi a o y challenge model o B. pe ussis
in ec ion, in which p o ec ion co ela es wi h accine e icacy
in human clinical ials, oge he wi h gene knockou mice, we
ha e iden i ied complemen a y oles o cellula and humo al
immuni y in p o ec ion [8–11]. In ou s udy, we used his model
o examine he ela ionship be ween he pe sis ence o he im-
mune esponse and he de elopmen o immunologic memo y
and p o ec ion agains espi a o y in ec ion.
Ma e ials and Me hods
Immuniza ion. BALB/c mice we e immunized in ape i oneally
(a 0 and 4 weeks) wi h 0.04 human dose o ei he Wellcome whole-
cell pe ussis accine (B i ish Re e ence eagen 88/522; Na ional
Ins i u e o Biological S anda ds and Con ol, Po e s Ba , He s-
o dshi e, UK) o Chi on acellula pe ussis accine (Chi on Vac-
cines, Siena, I aly), equi alen o 0.2 mg o ecombinan pe ussis
oxin (PT), 0.1 mg o ilamen ous hemagglu inin (FHA), and 0.1
mg o pe ac in (PRN). Con ol mice we e immunized wi h adju an
(alum) only.
Challenge and cou se o B. pe ussis in ec ion. Respi a o y in-
ec ion o mice wi h B. pe ussis was ini ia ed by ae osol challenge
as desc ibed elsewhe e [8]. The kine ics o bac e ial clea ance we e
de e mined by coun ing colony- o ming uni s (c u) in he lungs on
days 0, 3, 7, 14, and 21 a e challenge [8]. Resul s a e epo ed as
he mean numbe o iable B. pe ussis o indi idual lungs om
a leas 4 mice pe ime poin pe expe imen al g oup.
An ibody esponses. The le els o se um an ibody o B. pe -
ussis and bac e ial componen s we e de e mined by ELISA as
desc ibed elsewhe e [9]. B. pe ussis sonica e (5.0 mg/mL) o PT,
2088 Mahon e al. JID 2000;181 (June)
PRN, o FHA (1.0 mg/mL o each) we e used o coa pla es. Bound
an ibodies we e de ec ed by use o alkaline phospha ase–conju-
ga ed an i–mouse IgG. An ibody le els a e exp essed as he mean
end-poin i e (5SE), de e mined by ex apola ion o he s aigh
pa o he i a ion cu e o 2 SE abo e he backg ound alue
(OD <0.2) ob ained wi h nonimmune mouse se um. Assays we e
s anda dized wi h e e ence an ise um p epa ed om mice im-
munized wi h he B i ish e e ence p epa a ion o whole-cell pe -
ussis accines [9]. Ti e s >1/20 (1.3 log
10
) we e conside ed posi i e.
T cell cy okine assays. Spleen cells om indi idual mice we e
es ed a di e en ime poin s a e immuniza ion and a e chal-
lenge o in i o cy okine p oduc ion in esponse o hea -killed B.
pe ussis (10
6
/mL), PT (5.0 mg/mL; hea -inac i a ed a 807C o 20
min), FHA (5.0 mg/mL), PRN (5.0 mg/mL), concana alin A (2 mg/
mL), o medium alone as con ol. Supe na an s we e emo ed om
iplica e cul u es a e 72 h, and in e e on-gand in e leukin-4
concen a ions we e de e mined by immunoassay [7].
Assessmen o memo y B cells. An ibody- o ming cells we e
quan i ied by an insoluble subs a e B. pe ussis–speci ic ELISPOT.
The wells o pla es (Mul isc een HA; Millipo e, Bed o d, MA) we e
coa ed o e nigh wi h 100 mL o sonica ed B. pe ussis o inac i-
a ed PT (5 mg/mL). Bo h su aces o he memb ane we e washed
5 imes asep ically wi h PBS and hen we e blocked o 1 h wi h
8% ( ol/ ol) e al cal se um in RPMI medium. A e blocking,
spleen o pe iphe al blood mononuclea cell p epa a ions we e
added o quad uplica e wells a concen a ions om o
4
1310
/mL and we e incuba ed a 377C wi h 5% CO
2
o 2 days.
7
1310
A e being washed 6 imes in PBS, pla es we e incuba ed o 2 h
wi h ho se adish pe oxidase–conjuga ed goa an i–mouse IgG
(Sigma, Do se , UK). Pla es we e washed 3 imes mo e be o e he
addi ion o 200 mL/well 3-amino-9-e hylca bazole subs a e bu e .
A e 45 min, his was emo ed, and he pla es we e washed once
wi h wa e and allowed o ai d y. Spo s ep esen ing indi idual
an ibody- o ming cells we e coun ed by use o a zoom s e eo
mic oscope.
Resul s
Acellula and whole-cell pe ussis accines p o ec agains B.
pe ussis a e he disappea ance o se um IgG esponses. Im-
muniza ion o mice wi h 2 low doses o ei he a whole-cell o
an acellula pe ussis accine induced s ong se um IgG e-
sponses agains PT, FHA, and PRN, bu an ibody le els de-
clined apidly a e 3 mon hs and we e unde ec able by 6–9
mon hs ( igu e 1A). Immunized mice we e challenged wi h B.
pe ussis ei he a he peak o he an ibody esponse 6 weeks
a e p ima y immuniza ion o once ci cula ing an ibody i e s
had waned, 44 weeks a e p ima y immuniza ion. Despi e he
decline in B. pe ussis–speci ic se um IgG o unde ec able le els,
bo h accines s ill con e ed p o ec ion agains B. pe ussis
when challenged 44 weeks a e immuniza ion ( igu e 1B). The
numbe s o bac e ia in he lungs we e signi ican ly highe in
con ol han in ei he whole-cell accine– o acellula accine–
immunized mice a all ime poin s es ed ( ). In pa -P!.01–.001
icula , mice immunized wi h whole-cell pe ussis accines dis-
played a high le el o p o ec ion ha was equi alen o ha
obse ed a he peak o he an ibody esponse 6 weeks a e
immuniza ion; coun s o c u we e signi ican ly g ea e in whole-
cell accine– han in acellula accine–immunized mice 3, 7,
and 10 days a e challenge a 44 weeks.
Immuniza ion induces memo y T and B cells. Recall T cell
esponses o B. pe ussis an igens pe sis ed in whole-cell ac-
cine– and acellula accine–immunized mice, and, on he day
o challenge a 44 weeks a e p ima y immuniza ion, B. pe -
ussis–speci ic T cell esponses clea ly we e de ec able in im-
munized mice ( igu e 2A). Whole-cell pe ussis accine induced
a Th1-domina ed esponse, whe eas acellula pe ussis accine
induced a Th2- ype esponse, and hese pa e ns o cy okine
sec e ion pe sis ed o a leas 44 weeks. Howe e , 14 days a e
challenge, he cy okine p o ile o B. pe ussis an igen–s imula ed
spleen cells om mice immunized wi h acellula pe ussis ac-
cine had swi ched o a mixed Th1/Th2- ype esponse (18–33
ng/mL in e e on-gand 100–217 pg/mL in e leukin-4), whe eas
he Th1 esponse was main ained in mice immunized wi h
whole-cell pe ussis accine (58–160 ng/mL in e e on-gand
unde ec able in e leukin-4).
Memo y B cells speci ic o B. pe ussis also we e induced
by immuniza ion wi h whole-cell and acellula pe ussis ac-
cines and pe sis ed o a leas 44 weeks a e accina ion. By
use o an ELISPOT echnique, speci ic an ibody- o ming cells
we e de ec ed in pe iphe al blood mononuclea cells and spleen
cells a e s imula ion wi h PT o B. pe ussis sonica e ( igu e
2B). Signi ican ly g ea e numbe s o B. pe ussis–speci ic B cells
could be de ec ed in he blood and spleens o immunized mice
han in hose o con ols. Memo y induc ion was con i med by
he obse a ion o an anamnes ic an ibody esponse o B. pe -
ussis an igens in immunized mice a e challenge ( igu e 1A).
IgG esponses o B. pe ussis could no be de ec ed in unim-
munized con ol mice o a leas 21 days a e challenge. In
con as , 7 days a e challenge, ci cula ing an ibodies we e de-
ec ed agains PRN and B. pe ussis sonica e in whole-cell ac-
cine–immunized mice and agains PRN and PT in acellula
accine–immunized mice.
Discussion
Ou s udy demons a es ha ci cula ing an ibody, conside ed
o be he majo e ec o mechanism agains i uses and bac e ia,
need no be de ec able a he ime o exposu e o he main-
enance o accine-induced p o ec i e immuni y agains a bac-
e ial pa hogen o humans. P o ec i e le els o ci cula ing an-
ibody ha e been iden i ied o ce ain pa hogens, such as
polio i us, he agen s o diph he ia and e anus, and Haemo-
philus in luenzae. Howe e , ce ain pe sons who ha e an ibody
le els below hese h eshold alues appea o be p o ec ed. Fu -
he mo e, i has been di icul o es ablish p o ec i e le els o
an ibody induced wi h ce ain accines, including hose agains
pe ussis [1–4]. Recen epo s om household con ac s udies
ha e indica ed ha an ibody esponses o PT, PRN, and im-
JID 2000;181 (June) Pe ussis and Immunologic Memo y 2089
Figu e 1. Pe sis ence o p o ec ion agains Bo de ella pe ussis espi a o y in ec ion a e decline in speci ic se um IgG o unde ec able le els.
Mice we e immunized a weeks 0 and 4 wi h 0.04 human dose o whole-cell pe ussis accine (Pw) o acellula pe ussis accine (Pa) o wi h
adju an only as con ol. A, Se um an ibody esponses o B. pe ussis (BP) sonica e, pe ussis oxin (PT), ilamen ous hemagglu inin (FHA), and
pe ac in (PRN), de ec ed by ELISA a in e als a e immuniza ion and 1, 2, and 3 weeks a e espi a o y challenge. B, Immunized and con ol
mice a e exposu e o ae osol challenge wi h B. pe ussis 6 o 44 weeks a e p ima y immuniza ion. Resul s a e mean (5SE) colony- o ming
uni s (c u) in lungs, es ima ed o 4 mice/g oup a each ime poin (e o ba s a e smalle han symbols a ce ain ime poin s o con ol mice).
* ; ** , whole-cell s. acellula accine (Mann-Whi ney U es ).P!.05 P!.01
b iae may co ela e wi h absence o se e e disease [7, 12]. Al-
hough hese s udies sugges ed ha an ibodies o PRN and
imb iae a e he mos impo an , a monocomponen pe ussis
oxoid accine con e ed 71% p o ec ion agains se e e disease
in a clinical ial [4]. Fu he mo e, an ibody le els in child en
decline apidly a e accina ion [5, 6, 13]. The esul s o he
p esen s udy sugges ha , i exposed o B. pe ussis, hese chil-
d en s ill would be p o ec ed agains de eloping whooping
cough.
The e a e a numbe o explana ions o he main enance o
p o ec ion a e he decline in ci cula ing an i–B. pe ussis an-
ibody. I is possible ha an ibody does no play a ole in
p o ec ion and ha immuni y is con e ed exclusi ely by cel-
lula mechanisms. Analysis o cell-media ed immuni y in mice
demons a ed ha speci ic T cell esponses we e main ained up
o he ime o challenge, 44 weeks a e immuniza ion. Whole-
cell pe ussis accines selec i ely induced B. pe ussis–speci ic
Th1 cells, whe eas acellula pe ussis accines induced T cells
mo e pola ized o he Th2 sub ype, which is consis en wi h
epo s on sho - e m immuniza ion [8, 9]. We ha e sugges ed
elsewhe e ha he Th1 subpopula ion con e s op imal p o ec-
ion agains B. pe ussis [8–11] and ha hese cells may unc ion
by p omo ing he an ibac e ial ac i i y o mac ophages and
neu ophils and by s imula ing opsonizing an ibodies.Howe e ,
acellula pe ussis accines also can con e a high le el o p o-
ec ion agains se e e disease, and his appea s o be media ed
solely by an ibody wi h help om Th2 cells. The sligh ly lowe
le els o bac e ia in he lungs o whole-cell accine–immunized
mice, compa ed wi h acellula accine–immunized mice a e
challenge a 44 weeks, is consis en wi h p e ious s udies on
sho - e m p o ec ion wi h a ange o whole-cell and acellula
pe ussis accines [8] and may e lec he con ibu ion o cell-
media ed immuni y o p o ec ion. Ne e heless, he esul s sug-
ges ha he Th1/Th2 dicho omy does no impinge on memo y
2090 Mahon e al. JID 2000;181 (June)
Figu e 2. Recall T and B cell esponses o Bo de ella pe ussis an igens a e immuniza ion wi h whole-cell pe ussis accine (Pw) o acellula
pe ussis accine (Pa). A, 44 Weeks a e immuniza ion, spleen cells ( /mL) we e incuba ed wi h hea -inac i a ed pe ussis oxin (PT),
6
2310
ilamen ous hemagglu inin (FHA), pe ac in (PRN), hea -killed B. pe ussis (BP), concana alin A (Con A) o medium only as posi i e and nega i e
con ols, espec i ely. Supe na an s we e emo ed a e 72 h and assessed o in e e on-g(IFN-g) and in e leukin-4 (IL-4). Resul s a e mean
(5SE) cy okine concen a ions o 4 mice/g oup, assayed in iplica e. Cy okines we e unde ec able in supe na an s om cells s imula ed wi h
medium alone. B, 44 Weeks a e immuniza ion, pe iphe al blood mononuclea cells and spleen cells om immunized o con ol mice we e
incuba ed in pla es coa ed wi h B. pe ussis sonica e (BP) o inac i a ed PT, and nos. o speci ic an ibody- o ming cells (AFC) we e de e mined
by ELISPOT. Resul s a e mean alues (5SE) o iplica e de e mina ions om 4–6 mice/g oup. Cy okine and AFC da a a e ep esen a i e o
4 di e en ime poin s a e immuniza ion in 2 independen expe imen s, wi h simila le els o s a is ical signi icance a each de e mina ion.
* ; ** ; *** s. con ol (S uden ’s es ).P!.05 P!.01 P!.001
induc ion. Fu he mo e, al hough hese pa e ns o cy okine
sec e ion a e s able, hey a e no immu able o “locked in.”
A e bac e ial challenge, he e is a b oadening o he pa e n
o cy okine esponses obse ed in acellula pe ussis accine–
immunized mice, om a Th2 esponse 7 days a e challenge
o a mixed Th1/Th2 o Th0- ype esponse he ea e . In a s udy
o child en immunized wi h acellula pe ussis accines, he
mixed Th1/Th2 p o ile obse ed ea ly a e accina ion [14, 15]
had swi ched o a Th1- ype esponse 3–4 yea s la e [13]. I was
sugges ed ha exposu e o subclinical in ec ions, which would
enhance Th1 esponses, may explain he pe sis en p o ec ion
agains ypical pe ussis, despi e a subs an ial waning o bo h
an ibody and T cell esponses induced by he p ima y immu-
niza ion [13].
An al e na i e, bu no mu ually exclusi e, hypo hesis o ex-
plain long- e m p o ec ion in child en a e declining an ibody
esponses is ha immune e ec o mechanisms gene a ed om
memo y B and T cells a e bac e ial exposu e a e capable o
clea ing he bac e ia om he espi a o y ac . This is consis-
en wi h ou s udy and wi h ecen sugges ions ha an ibodies
agains mul iple an igens can media e p o ec ion agains B. pe -
ussis [3, 8]. Gi en he long incuba ion pe iod o B. pe ussis
in ec ion, anamnes ic an ibody esponses a e exposu e may
be su icien o p o ec agains se e e whooping cough. How-
e e , i appea s ha cu en pe ussis accines do no con e
s e ilizing immuni y agains B. pe ussis. These accines a e
capable o p e en ing se e e disease bu a e less e icien when
judged on he c i e ion o p e en ing in ec ion o mild disease,
e en in he p esence o high le els o ci cula ing an ibody a
he ime o in ec ion. Al hough he induc ion o a gi en con-
cen a ion o ci cula ing an ibody ea ly a e accina ion may
s ill p o ide a use ul co ela e o p o ec ion, in ha i may
p edic he le el o B cell p iming, i is no clea ha i will
p edic he ex en o memo y T and B cell induc ion. Al hough
we do no ye ha e de ini i e in o ma ion on he ela i e im-
po ance o T o B cell memo y, we ha e demons a ed else-
JID 2000;181 (June) Pe ussis and Immunologic Memo y 2091
whe e ha sho - e m memo y B and T cells bo h con ibu e
o p o ec ion induced by na u al in ec ion [10].
Ou indings ha e impo an implica ions o pe ussis ac-
cina ion policy in ela ion o he le el o p o ec ion in he ace
o waning an ibody le els and he need o boos e immuni-
za ion. The da a om he mouse model sugges ha pe sis ence
o ci cula ing an ibody is no a p e equisi e o he main enance
o p o ec i e immuni y. These obse a ions also ha e impli-
ca ions o he e alua ion and de elopmen o accines agains
a ange o in ec ious diseases. Al hough ci cula ing neu alizing
an ibodies clea ly a e impo an o con e s e ilizing immuni y,
especially agains i al in ec ions, i also appea s ha ce ain
accines can p o ec by ecall o immunologic memo y a he
T and B cell le el.
Acknowledgmen s
We hank Ge aldine Mu phy and Helen S ewa o echnical assis-
ance and Chi on Vaccines (Siena, I aly) o supplying pe ussis ac-
cines and an igens.
Re e ences
1. G eco DD, Salmaso S, Mas an onio P, e al. A con olled ial o wo
acellula accines and one whole-cell accine agains pe ussis. N Engl J
Med 1996;334:341–8.
2. Gus a sson L, Hallande HO, Olin P, Reizens ein O, S o sae e J. A con olled
ial o a wo-componen acellula , a i e-componen acellula , and a
whole-cell pe ussis accine. N Engl J Med 1996;334:349–55.
3. Olin P, Rasmussen F, Gus a sson L, Hallande HO, Heijbel H. Randomised
con olled ial o wo-componen , h ee-componen , and i e-componen
acellula accines compa ed wi h whole-cell pe ussis accine. Lance
1997;350:1569–77.
4. T oll o s B, Ta ange J, Lage ga˚ d T, e al. A placebo-con olled ial o a
pe ussis- oxoid accine. N Engl J Med 1995;333:1045–50.
5. Giuliano M, Mas an onio P, Giammanco A, Pisci elli A, Salmaso S, Was-
silak SG. An ibody esponses and pe sis ence in he wo yea s a e im-
muniza ion wi h wo acellula accines and one whole-cell accine agains
pe ussis. J Pedia 1998;132:983–8.
6. Salmaso S, Mas an onio P, Wassilak SG, e al. Pe sis ence o p o ec ion
h ough 33 mon hs o age p o ided by immuniza ion in in ancy wi h wo
h ee-componen acellula pe ussis accines. Vaccine 1998;16:1270–5.
7. S o sae e J, Hallande HO, Gus a sson L, Olin P. Le els o an i-pe ussis
an ibodies ela ed o p o ec ion a e household exposu e o Bo de ella
pe ussis. Vaccine 1998;16:1907–16.
8. Mills KHG, Ryan M, Ryan E, Mahon BP. A p edic i e model o pe ussis
accine e icacy in child en e eals complemen a y oles o humo al and
cell media ed immuni y in p o ec ion. In ec Immun 1998;66:594–602.
9. Redhead K, Wa kins J, Ba na d A, Mills KHG. E ec i e immuniza ion
agains Bo de ella pe ussis espi a o y in ec ion in mice is dependen on
induc ion o cell-media ed immuni y. In ec Immun 1993;61:3190–8.
10. Mills KHG, Ba na d A, Wa kins J, Redhead K. Cell media ed immuni y o
Bo de ella pe ussis: ole o Th1 cells in bac e ial clea ance in a mu ine
espi a o y in ec ion model. In ec Immun 1993;61:399–410.
11. Mahon BP, Sheahan BJ, G i in F, Mu phy G, Mills KHG. A ypical disease
a e Bo de ella pe ussis espi a o y in ec ion o mice wi h a ge ed dis-
up ions in IFN-g ecep o o immunoglobulin mchain genes. J Exp Med
1997;186:1843–51.
12. Che y JD, Go nbein J, Heininge U, S eh K. A sea ch o se ologic co -
ela es o immuni y o Bo de ella pe ussis cough illnesses. Vaccine 1998;16:
1901–6.
13. Ausiello CM, Lande R, U bani F, e al. Cell-media ed immune esponses in
ou -yea -old child en a e p ima y immuniza ion wi h acellula pe ussis
accines. In ec Immun 1999;67:4064–71.
14. Ausiello CM, U bani F, La Sala A, Lande R, Cassone A. Vaccine- and
an igen-dependan ype 1 and ype 2 cy okine induc ion a e p ima y
accina ion o in an s wi h whole-cell o acellula pe ussis accines.In ec
Immun 1997;65:2168–74.
15. Ryan M, Mu phy G, Ryan E, e al. Dis inc Th cell sub ypes induced wi h
whole-cell and acellula pe ussis accines in child en. Immunology
1998;93:1–10.